Premier Alternatives

EarLens

Menlo Park, CA · Founded 2005 · Privately Held (backing)

Developer of a contact hearing technology device designed to change the current standard of care for sound performance. EarLens is based in Menlo Park, CA and was founded in 2005. It was valued at $23 million at its later-stage round in Feb 2025, the last priced event on record. It has raised $331 million across 11 recorded rounds; the latest was an $8 million early-stage round in Feb 2025.

PMV mark · valuation
$23.0M
Oct 2026
Priced at
its later-stage round
Feb 2025
Total raised
$330.6M
Last round
Early Stage VC
Feb 2025

EarLens key facts

as of Oct 2026
  • Developer of a contact hearing technology device designed to change the current standard of care for sound performance.
  • EarLens is valued at approximately $23.0M as of Oct 2026, set at its later-stage round, Feb 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $330.6M across 11 recorded rounds; the latest was Early Stage VC ($8.0M) in Feb 2025.
  • Notable investors include EXOR Seeds, Lightstone Ventures, Richard King Mellon Foundation, KCK Group, Far East Capital (Singapore) — 24 tracked in total.
  • EarLens has filed 17 Form Ds with the SEC since 2010, most recently Mar 2025 ($8.0M sold to 6 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$23.0M

Valued at $23.0M at its later-stage round, Feb 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of EarLens with a free account
  • ·The complete investor list: 24 names
  • ·Watch EarLens: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

EarLens funding rounds

11 rounds
Feb 2025Early Stage VC$8.0MSEC filing▮
Apr 2024Early Stage VC$18.8MSEC filing▮
Apr 2022Early Stage VC$6.0MSEC filing▮
Aug 2021Early Stage VC$21.2MSEC filing▮
Dec 2020Early Stage VC$33.2MSEC filing▮
Full funding history →

EarLens valuation

EarLens was valued at $23 million at its later-stage round in Feb 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has EarLens raised?

EarLens has raised $331 million across 11 recorded rounds since 2013. The largest was a $9 million early-stage round in May 2018; the most recent was an $8 million early-stage round in Feb 2025.

EarLens has filed 17 Form Ds with the SEC since 2010, most recently in Mar 2025 ($8 million sold to 6 investors).

EarLens investors

24 investors are on record for EarLens, including EXOR Seeds, Lightstone Ventures, Richard King Mellon Foundation and KCK Group. The early-stage round in Feb 2025 drew 6 investors.

About EarLens

Developer of a contact hearing technology device designed to change the current standard of care for sound performance. The company's device utilizes low-frequency radio and a small lens placed on the eardrums to directly activate the natural hearing system and automatically adjusts to challenging listening environments with natural sound and minimal feedback, enabling hearing-impaired patients to hear clearly while minimizing the potential for feedback.

Sector
Healthcare
HQ
Menlo Park, CA, United States
Founded
2005
Employees
108
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.